Drugs / LEVOMENTHOL
LEVOMENTHOL
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT07500974 | May 2026 → Apr 2027 expected | asthma | Region Skane | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07398287 | Apr 2026 → Feb 2027 expected | interstitial lung disease | Region Skane | Recruiting | No outcome recorded |
| Phase 2 | NCT05888597 | May 2023 → Apr 2025 | chronic obstructive pulmonary disease | Region Skane | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT04593836 | Mar 2012 → Dec 2020 | — | Taipei Veterans General Hospital, Taiwan | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03132142 | Apr → Aug 2017 | neurological pain disorder, skin disorder | Aalborg University | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT04097574 Comparator | Aug 2019 → Mar 2020 | intestinal disorder | Nihon Pharmaceutical Co., Ltd | Completed | No outcome recorded |
| Phase 3 | NCT00742599 Comparator | Sep 2008 → Apr 2009 | — | Nihon Pharmaceutical Co., Ltd | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LEVOMENTHOL | ChEMBL registry synonym — accepted as the source's own label CHEMBL470670 ↗ |
| Known as | L-menthol | “Antiperistaltic effect and safety of L-menthol sprayed on the gastric mucosa for upper GI endoscopy: a phase III, multicenter, randomized, double-blind, placebo-controlled study.” PMID 21353674 ↗ Feb 2011 |
| Known as | Levomentol | ChEMBL registry synonym — accepted as the source's own label CHEMBL470670 ↗ |
| Modality | Small molecule | — CHEMBL470670 ↗ |
| Route | Topical | “Both treatments were sprayed endoscopically on the gastric mucosa.” PMID 21353674 ↗ Feb 2011 |